ArticleFrontiers in oncology2026

Case Report: squamous transformation after long-term osimertinib in EGFR-mutant lung adenocarcinoma with retained EGFR/TP53 alterations.

Lina Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.